Highly rated in
Highly rated in
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Steven C. Kirshblum's experience treating your condition:
About Dr. Steven C. Kirshblum

Steven Kirshblum is a Physiatrist in West Orange, New Jersey. Kirshblum has been practicing medicine for over 37 years and is highly rated in 5 conditions, according to our data. His top areas of expertise are Paraplegia, Autonomic Dysreflexia, Neurogenic Bowel, Spasticity, and Hormone Replacement Therapy (HRT). He is licensed to treat patients in New Jersey. Kirshblum is currently accepting new patients.

His clinical research consists of co-authoring 139 peer reviewed articles and participating in 11 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Steven C. Kirshblum it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Steven C. Kirshblum accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
1199 Pleasant Valley Way, West Orange, NJ 07052
Background & Education
Graduate Institution
R Franklin University Of Med & Sci/chicago Medical School, 1986
Physical Medicine & Rehabilitation in NJ
Hospital Affiliations
Kessler Institute For Rehabilitation - West Orange
Cooperman Barnabas Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Effect of Extracorporeal Shockwave Therapy on Spasticity in Chronic SCI: A Pilot Study
Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury
Treatment of Chronic Shoulder Pain in Persons With Spinal Cord Injury Using Injection With Autologous Micro-Fragmented Adipose Tissue Under Ultrasound Guidance
The Efficacy of Denosumab to Reduce Osteoporosis After Spinal Cord Injury
The Effect of Whole Body Vibration on Spasticity in Spinal Cord Injury Patients
Prevention of Long-Term Respiratory Complications of Spinal Cord Injury: a Randomized Controlled Trial
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors